Biomedical Engineering Reference
In-Depth Information
69. Gong K, Rehman IU, Darr JA (2007) Synthesis of poly(sebacic anhydride)-indomethacin
controlled release composites via supercritical carbon dioxide assisted impregnation. Int J
Pharm 338:191-197
70. Gong K, Braden M, Patel MP, Rehman IU, Zhang Z, Darr JA (2007) Controlled release
of chlorhexidine diacetate from a porous methacrylate system: supercritical fluid assisted
foaming and impregnation. J Pharm Sci 96:2048-2056
71. Gong K, Rehman IU, Darr JA (2008) Characterization and drug release investigation of
amorphous drug-hydroxypropyl methylcellulose composites made via supercritical carbon
dioxide assisted impregnation. J Pharmaceut Biomed Anal 48:1112-1119
72. Banchero M, Manna L, Ronchetti S, Campanelli P, Ferri A (2009) Supercritical solvent
impregnation of piroxicam on PVP at various polymer molecular weights. J Supercrit Fluids
49:271-278
73. Lopez-Periago A, Argemi A, Andanson JM, Fernandez V, Garcia-Gonzalez CA, Kazarian SG,
Saurina J, Domingo C (2009) Impregnation of a biocompatible polymer aided by supercritical
CO
2
: evaluation of drug stability and drug-matrix interactions. J Supercrit Fluids 48:56-63
74. Cabodi M, Cross V, Qu Z, Havenstrite KL, Schwartz S, Stroock AD (2006) An active wound
dressing for controlled convective mass transfer with the wound bed. J Biom Mat Res Part B
13:210-220
75. Seydim AC, Sarikus G (2006) Antimicrobial activity of whey protein based edible films
incorporated with oregano, rosemary and garlic essential oils. Food Res Int 39:639-644
76. Alvarez M, Zarelli VEP, Pappano NB, Debattista NB (2004) Bacteriostatic action on synthetic
polyhydroxylates chalcones against escherichia coli. Biocell 28:31-34
77. Manach C, Williamson G, Morand C, Scalbert A, Remesy C (2005) Bioavailability and
bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies. Am J Clin
Nutr 81:230S-242S
78. Perron NR, Brumaghim JL (2009) A review of the antioxidant mechanisms of polyphenol
compounds related to iron binding. Cell Biochem Biophys 53:75-10
79. Boots AW, Haenen GR, Bast A (2008) Health effects of quercetin: from antioxidant to
nutraceutical. Eur J Pharmacol 582:325-337
80. Pace-Asciak CR, Hahn S, Diamandis EP (1995) The red wine phenolics trans-resveratrol
and quercetin block human platelet aggregation and eicosanoid synthesis: implications for
protection against coronary heart disease. Clin Chim Acta 235:207-219
81. Saija A, Scalese M, Lanza M (1995) Flavonoids as antioxidant agents: importance of their
interaction with biomembranes. Free Radic Biol Med 19:481-486
82. Miller AL (1996) Antioxidant flavonoids: structure, function and clinical usage. Altern Med
Rev 1:103-111
83. Kuhlmann MK, Burkhardt G, Horsch E (1998) Inhibition of oxidant-induced lipid perox-
idation in cultured renal tubular epithelial cells (LLC-PK1) by quercetin. Free Radic Res
29:451-460
84. O'Reilly JD, Sanders TA, Wiseman H (2000) Flavonoids protect against oxidative damage
to LDL in vitro: use in selection of a flavonoid rich diet and relevance to LDL oxidation
resistance
ex vivo
? Free Radic Res 33:419-426
85. Raso GM, Meli R, Di Carlo G (2001) Inhibition of inducible nitric oxide synthase and
cyclooxygenase 2 expression by flavonoids in macrophage J774A.1. Life Sci 68:921-931
86. Kaul TN, Middleton E Jr, Ogra PL (1985) Antiviral effect of flavonoids on human viruses.
J Med Virol 15:71-79
87. Zhang Y, Yang Y, Tang K, Hu X, Zou G (2008) Physicochemical characterization and antiox-
idant activity of quercetin-loaded chitosan nanoparticles. J Appl Polym Sci 107:891-897
88. Gugler R, Leschik M, Dengler HJ (1975) Disposition of quercetin in man after single oral and
intravenous doses. Eur J Clin Pharmacol 9:229-234
89. Manach C, Regerat F, Texier O (1996) Bioavailability, metabolism and physiological impact
of 4-oxoflavonoids. Nutr Res 16:517-534
